This pharma company makes a miracle HIV drug, but is blocking access for millions of low-income people

By most accounts, the HIV drug lenacapavir is so effective in preventing infection and treating HIV-positive patients that it could revolutionize the fight against AIDS. “Lenacapavir could be transformative,” says Peter Maybarduk, director of the access to medicines program at the nonprofit organization Public Citizen, “if people can get it.” What’s the main obstacle? It’s []